Taken together with our observations that ZEB1 overexpression decreases breast cancer cell sensitivity to EPI and ETOP treatment in an ATM-dependent fashion, ATM upregulation may at least partially account for the resistance of this subset of breast cancers against chemotherapy. This evidence concerns the gene ZEB1 and breast cancer.